Sight Sciences Inc SGHT
News
Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15
TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease
Sight Sciences Reports Second Quarter 2026 Financial Results
Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems
Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System
